Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE
Go back to Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 14.29 +0.16 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.13 | 52 Week High | $3.65 | |||
| Open | $14.29 | 52 Week Low | $1.24 | |||
| Day High | $14.55 | P/E | N/A | |||
| Day Low | $14.09 | EPS | $0.00 | |||
| Volume | 30,884 | |||||

